- Fellowship: Johns Hopkins Hospital (Hematology)
- Fellowship: Johns Hopkins Hospital (Hematology)
- Fellowship: Case Western Reserve University (Critical Care)
- Chief Resident: Case Western Reserve University
- Internship: Case Western Reserve University (Internal Medicine)
- Master's Degree: Tulane University School of Public Health (Medicine and Health Systems Mangement)
- Medical Degree: Tulane University School of Medicine
- Bachelor's Degree: University of Notre Dame (Pre-Professional Studies and Political Science)
American Board of Internal Medicine (Critical Care Medicine) (Certification Date: 20201215)
American Board of Internal Medicine (Hematology) (Certification Date: 20191025)
American Board of Internal Medicine (Certification Date: 20150811)
Critical Care Medicine
Hematology
Internal Medicine
- Vontz Center
- Office 513-558-2115
- Email hamblebc@ucmail.uc.edu
Clinical Interests
Critical Care Medicine
Hematology and Oncology
Leukemia
Acute Lymphocytic Leukemia
Acute Myeloid Leukemia
Amyloidosis
Castleman Disease
Chronic Lymphocytic Leukemia
Chronic Myelogenous Leukemia
Lymphadenopathy
Lymphoma
M Protein
Macrocytosis
Mediastinal Adenopathy
Monoclonal gammopathy
Monoclonal protein
M-Spike
Mycosis Fugoides
Myelodysplastic Syndrome
Myeloma
Myeloproliferative Disorder
Paraproteinemia
Plasma Cell Disorder
Plasminogen Activator Inhibitor 1
Polycythemia vera
Proteinuria
Sideroblastic anemia
T-cell lymphoma
Peer Reviewed Publications
Alex Ambinder, Bryan Hambley, Satish Shanbhag, and Sam Merrill 2019. Ibrutinib-associated hemophagocytic lymphohistiocytosis: A case series from Johns Hopkins American Journal of Hematology, ,
Bryan Hambley, Kelly Norsworthy, Jagar Jasem, Jacquelyn Zimmerman et al. 2019. Fibrinogen consumption and use of heparin are risk factors for delayed bleeding during acute promyelocytic leukemia induction Leukemia Research, ,
Eric Gehrie et al. 2019. One-unit compared to two-unit platelet transfusions for adult oncology outpatients Vox Sanguinis, ,
Bryan Hambley, Paolo Caimi, and Basem William 2016. Bortezomib for the treatment of mantle cell lymphoma: an update Therapeutic Advances in Hematology, ,